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Background: The toxicity of manufactured fumed silica nanoparticles (NPs) remains poorly investigated compared
to that of crystalline silica NPs, which have been associated with lung diseases after inhalation. Amorphous silica
NPs are a raw material for manufactured nanocomposites, such as cosmetics, foods, and drugs, raising concerns
about their potential toxicity.
Results: The size of the NPs was determined by dynamic light scattering and their shape was visualized by atomic
force microscopy (10 ± 4 nm). The pertinent toxicological concentration and dynamic ranges were determined
using viability tests and cellular impedance. We combined transcriptomics and proteomics to assess the cellular and
molecular effects of fumed silica in A549 human alveolar epithelial cells. The “no observed transcriptomic adverse
effect level” (NOTEL) was set to 1.0 μg/cm2, and the “lowest observed adverse transcriptional effect level” (LOTEL)
was set at 1.5 μg/cm2. We carried out genome-wide expression profiles with microarrays and identified, by shotgun
proteomics, the exoproteome changes in lung cells after exposure to NP doses (0.1, 1.0, 1.5, 3.0, and 6.0 μg/cm2) at
two time points (24 h and 72 h). The data revealed a hierarchical, dose-dependent cellular response to silica NPs. At
1.5 μg/cm2, the Rho signaling cascade, actin cytoskeleton remodeling, and clathrin-mediated endocytosis were
induced. At 3.0 μg/cm2, many inflammatory mediators were upregulated and the coagulation system pathway was
triggered. Lastly, at 6.0 μg/cm2, oxidative stress was initiated. The proteins identified in the extracellular compartment
were consistent with these findings.
Conclusions: The alliance of two high-throughput technologies allowed the quantitative assessment of the cellular
effects and molecular consequences of exposure of lung cells to low doses of NPs. These results were obtained
using a pathway-driven analysis instead of isolated genes. As in photography, toxicogenomics allows, at the same
time, the visualization of a wide spectrum of biological responses and a “zoom in” to the details with a great depth
of field. This study illustrates how such an approach based on human cell culture models is a valuable predictive
screening tool to evaluate the toxicity of many potentially harmful emerging substances, alone or in mixtures, in
the framework of future regulatory reinforcements.
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With the growing commercialization of nanotechnology
products, human exposure to manufactured nanoparti-
cles (NPs) is increasing, raising concerns about their po-
tential toxicity. Synthetic, amorphous silica NPs are a
raw material for the manufacture of many nanocompos-
ites, such as cosmetics, foods, drugs, and printing ink
additives, on a large industrial scale [1]. The toxicity of
crystalline silica, the inhalation of which is involved in
many lung diseases, such as silicosis, lung cancer,
chronic obstructive pulmonary diseases, and pulmonary
tuberculosis, has been widely studied [1,2]. However, few
studies have been performed on amorphous silica, be-
cause it exists in many diverse forms of natural or syn-
thetic origin [3,4]. Industrial processes use synthetic
amorphous silica nanoparticles for the easy control of
size, shape and physical properties. Fumed (or pyro-
genic) silica is prepared by the oxidation of silicon tetra-
chloride at elevated temperature, leading to a very low
bulk density and high specific surface area nanopowder
(200 m2/g for AEROSIL® 200 NPs). Fumed silica is used
extensively as strengthening filler and thickening agent
in a wide variety of products, such as foodstuffs, paints,
printing inks (toners) and adhesives. It also serves as a
desiccant and is frequently added to cosmetics and
toothpastes due to its respective light-diffusing and
mild-abrasive properties. Along with applications in
polyester, silicone, paints, and coatings, hydrophilic
fumed silica AEROSIL® products are used with increas-
ing success in high-technology fields such as electronics
and optical fiber industries. Fumed silica poses an inhal-
ation risk due to its extremely fine structure and the
workers synthesizing or using it may be the first popula-
tion exposed.
Some in vivo toxicological studies have been carried
out with AEROSIL products. Reuzel et al. showed that
AEROSIL® 200 (30 mg/m3) led to a clear dose–response
relationship and to the accumulation of alveolar macro-
phages [5]. Of the amorphous silicas examined, AERO-
SIL® 200 induced the most severe changes in the lungs
of rats, which only partly recovered. Previous in vitro
studies also showed that amorphous silica nanoparticles
were toxic to lung cells [4,6,7].
While in vivo toxicity assays in animals remain the
gold-standard methodology for evaluating the toxicity of
a compound, the existence of a growing number of man-
ufactured products mandates an urgent requirement for
alternative assays based on high-throughput, cell-based
methodologies. Toxicogenomics, including in its broader
scope transcriptomics and proteomics, is a promising
tool not only for monitoring the toxicity of substances
using human cell line assays but also for investigating
and documenting the modes of action of unknown che-
micals [8-12]. In this domain, Lobenhofer [13] developeda new concept that could potentially be a new, sensitive,
and informative parameter to be systematically docu-
mented for risk assessment and comparison [14]. This
parameter is the highest concentration of a given chem-
ical for which no effect on the transcriptome is observed
and is named the “no observed transcriptional effect
level” (NOTEL). Proteomics has, in addition, been pro-
posed as a complementary approach to study the cellular
response to toxicants [15]. Specifically, the analysis of
human cell line secretomes appears to be a promising
source of biomarkers documenting their physiological
state in response to chemicals [16].
Here, we have focused on the cellular effects induced
by fumed silica NPs (AEROSIL® 200 NPs) in A549 lung
epithelial cells. For this, we established the transcrip-
tomic dose–response curve over a range of silica con-
centrations and accurately determined the NOTEL
threshold using commercial human 4x44k Gene Expres-
sion Microarrays. We also performed, by high-resolution
shotgun proteomics, an analysis of the secretome of
A549 cells after exposure. This new strategy allowed the
highlighting, in a dose-dependent manner, of the signifi-
cant cellular and molecular modifications triggered by
the exposure to fumed silica NPs.
Results
Characterization of silica NPs
The silica NPs were first characterized in terms of aggrega-
tion and size. In DMEM/F12 culture medium comprising
10% fetal bovine serum (FBS), the average hydrodynamic
diameter of the NPs was 10 ± 4 nm, as measured by dy-
namic light scattering (DLS). This value is close to the
value provided by the manufacturer (12 nm). NPs in
serum-free medium were in an agglomerated form
with a mean size, evaluated by DLS, close to 350 nm
(±8 nm). Atomic Force Microscopy (AFM) showed dis-
perse disks with diameter 10 ± 5 nm and thickness 2 ±
0.3 nm (Figure 1A) and confirmed the existence of size
heterogeneity. Figure 1B shows a typical 160 ± 90 nm
agglomerate, where individual base units are clearly
visible.
Viability tests and real-time cellular impedance
We evaluated the cytotoxicity of SiO2 NPs in A549 human
alveolar epithelial cells in serum-free medium. Two differ-
ent toxicity assays, ATP (Cell Titer Glo, Promega) and
XTT (TOX-2, Sigma), were carried out. These two assays
comprised two different reporting systems – fluorescence
and optical density, respectively – and were performed in
parallel to identify potential bias due to possible interfer-
ence from the nanoparticles. The ATP test based on the
intracellular ATP content measurement is considered as
a very sensitive viability test. The XTT test is based on
the activity of succinate dehydrogenase, a mitochondrial
Figure 1 AFM characterization of fumed silica AEROSIL® 200 NPs.
5 μL of AEROSIL® 200 NPs suspension (10 μg/mL in water) were
deposited on freshly cleaved mica then dried under vacuum. AFM
imaging was recorded with a Multimode and Nanoscope V
instrument (Veeco, Santa Barbara, CA, USA). The scale of false colors
spectrum code ranges from 0 to maximum height (in nm) using
Gwyddion software. A) AFM imaging shows average size of
individual disperse disks with diameter 10 ± 5 nm and thickness
2 nm ± 0.3 nm. An agglomerate is observed in the upper right side.
B) Details of AFM imaging of SiO2 NPs agglomerate in the same
sample. The average size of agglomerates is 160 ± 90 nm. In the inset,
a zoom of a SiO2 agglomerate, recorded with peak force phase, reveals
details of individual members clustered in the agglomerate.
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MTT test. Indeed, the formation of insoluble MTT forma-
zan in this assay is often interlaced with NP fibers or ag-
glomerates, thus inhibiting its solubilization by the solvent
[17,18]. As shown in Figure 2, both the ATP and XTT
tests produced similar dose–response curves over the
concentration range tested, from 0.3 - 30.3 μg/cm2 of cell
surface. AEROSIL® 200 NPs were cytotoxic from 3.0 -
30.3 μg/cm2. The no observed adverse effect level
(NOAEL) for these NPs was estimated at 1.5 μg/cm2 and
the lowest value for which an effect on cell viability wasobserved (LOAEL) was established at 3.0 μg/cm2 silica
NPs (Figure 2).
An xCELLigence RTCA instrument was used to carry
out real-time cell monitoring after exposure to NPs
(Figure 3). The highest concentrations (i.e. 25 and
50 μg/cm2) induced a drastic decrease in cell index
(CI) compared with control cells. The lowest concentra-
tions (1.5, 3.0, and 6.0 μg/cm2) indicated a biphasic CI
evolution with an early increase, followed by a decrease
up to the end of the experiment.
Omics-based probing of the silica NP cellular effects
Correlation between gene expression profiles and viability
assays
Gene expression changes depending on silica NP con-
centrations were evaluated in three biological replicates
with Agilent Human V2 4x44K Microarrays. Figure 4
shows the number of differentially expressed genes de-
tected in response to 0.1, 1.0, 1.5, 3.0, and 6.0 μg/cm2
AEROSIL® 200 silica NPs during 24 h exposure. A dose-
dependent response to silica NPs was observed, ranging
from 5 to 2,258 significantly differentially modulated
transcripts compared with controls, with a fold change
of at least 1.5 and p-value < 0.05. The lists of modulated
transcripts including fold changes and p-values are pre-
sented in Additional file 1: Table S1. These results
showed a strong correlation between the numbers of
modulated genes and the cell death percentage estab-
lished with viability tests (ATP, XTT). From these re-
sults, the NOTEL was set at 1.0 μg/cm2, with two
successive concentrations (0.1 and 1.0 μg/cm2) giving no
significantly differentially expressed genes as the criter-
ion (Figure 4). The LOTEL was set at 1.5 μg/cm2, with
255 transcripts as compared with controls. Figure 5A
shows the numbers of differentially expressed transcripts
obtained with 3.0 and 6.0 μg/cm2 silica NPs, and their
overlaps. A strong concordance of the results is repre-
sented by the Venn diagram (Figure 5A). At 24 h, more
than 80% of the transcripts modulated at 3.0 μg/cm2
were also modulated at 6.0 μg/cm2. Finally, the 3.0 and
6.0 μg/cm2 doses were also analyzed with whole genome
microarrays after 72 h exposure, to further identify po-
tentially conserved adverse outcome pathways. We
found 983 and 3,221 modulated transcripts at 3.0 and
6.0 μg/cm2, respectively. After 72 h exposure, 88% of the
transcripts modulated at 3.0 μg/cm2 were also modu-
lated at 6.0 μg/cm2.
Exoproteome changes upon silica NP addition
To determine which secreted proteins were modulated
upon silica NP exposure to 3.0 and 6.0 μg/cm2 doses at
24 h, we collected the supernatants of cell cultures from
the transcriptomic experiments. This ensured that the
data from both of these omics-based approaches were
Figure 2 Cell viability of A549 cells exposed to fumed silica AEROSIL® 200 NPs. After 24 h exposure to silica AEROSIL® 200 NPs, the viability of
A549 cells was determined using the ATP test (black line) (Cell Titer Glo, Promega) and the XTT test (red line) (TOX2, Sigma). The results are
expressed as the mean percent viable cells ± SD (n = 3) compared with unexposed cells.
Figure 3 XCELLigence experiment. Real-time cell index (CI) monitoring of A549 cells (n = 3) exposed to 1.5, 3.0, 6.0, 25, and 50 μg/cm2 fumed
silica AEROSIL® 200 NPs for 72 h. The black arrow represents the starting point of exposure. Cell index was normalized on baseline (control cells)
to ensure inter-dose comparison. The highest concentrations (i.e. 25 and 50 μg/cm2) induced a drastic CI decrease compared to control cells. The
lowest concentrations (1.5, 3.0 and 6.0 μg/cm2) indicated a biphasic CI evolution with an early increase followed by a decrease up to the end of
the experiment.
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Figure 4 Transcriptomic dose–response curve compared with ATP
assay. A549 cells (n = 3) were exposed for 24 h to increasing
concentrations of fumed silica AEROSIL® 200 NPs (0.1, 1.0, 1.5, 3.0,
and 6.0 μg/cm2). Blue histograms represent the number of
differentially expressed genes after statistical analysis with
Genespring software (Agilent). The black curve indicates the cell
death percentage obtained with the ATP viability test related to
the concentration of silica nanoparticles. The NOTEL (no observed
transcriptional effect level) was determined to be 1.0 μg/cm2 and
the LOTEL (lowest observed transcriptional effect level) as 1.5 μg/cm2.
The NOAEL (no observed adverse effect level) was determined as
1.5 μg/cm2 and the LOAEL (lowest observed adverse effect level)
at 3.0 μg/cm2.
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proteolysis of the three biological replicates at the three
conditions (zero, 3.0, and 6.0 μg/cm2 NPs), the resulting
peptides were analyzed by shotgun proteomics, i.e. nano-
LC resolution on a reverse phase coupled to tandem massFigure 5 Venn diagrams of significantly modulated genes and proteins (p-
concentrations of fumed silica AEROSIL® 200 NPs (3.0 and 6.0 μg/cm2). A) N
supernatants. More than 80% of the modulated molecules present at 3.0 μspectrometry operated with an Orbitrap mass analyzer. A
total of 8,276 MS/MS spectra were assigned with confi-
dence to human proteins (p-value ≤ 0.05) taking the nine
samples into consideration, indicating the presence of 145
proteins (Additional file 2: Table S2). Figure 5B reports
the number of significantly modulated proteins detected
with this approach in the extracellular medium upon
exposure to silica NPs. A total of 72 and 79 proteins
were significantly modulated with 3.0 and 6.0 μg/cm2
at 24 h, respectively, with a fold change of at least 2.0
(p-value ≤ 0.05). As for transcriptomics, the Venn dia-
gram showed a good correlation of the results between
silica NP doses, with more than 80% of the proteins
that were modulated at 3.0 μg/cm2 also modulated at
6.0 μg/cm2 (Figure 5B).
Canonical pathway analysis
Transcriptomic analysis
We identified the most relevant canonical pathways dis-
turbed after 24 and 72 h exposure at all NP doses using
the Ingenuity Pathway Analysis tool. Each canonical
pathway is constituted of a finite number of genes. For
each dose and time point, we calculated a ratio indicating
the percentage of altered genes in our dataset belonging to
a given canonical pathway. These pathways are all signifi-
cant according to a Fisher statistical test (p-value < 0.05).
Figure 6 reports the seven canonical pathways mainly
altered by fumed silica NPs in a time- and dose-dependent
manner. The most highly altered canonical pathways were
related to the “coagulation system”, including “intrinsic”
and “extrinsic” “prothrombin activation pathways”.
Other pathways linked to the cell response, and in-
volved at both times and both doses, included “acute
phase response signaling”, “xenobiotic metabolism signaling”,
“TREM1 signaling” and “oxidative stress response”. Some
pathways are not represented in Figure 6 because they
were only engaged at the lowest dose (1.5 μg/cm2). Thesevalue≤ 0.05). A549 cells (n = 3) were exposed for 24 h to increasing
umber of modulated genes. B) Number of modulated proteins in
g/cm2 were also modulated at 6.0 μg/cm2 in both omics analyses.
Figure 6 Altered canonical pathways. A549 cells (n = 3) were exposed for 24 h and 72 h to increasing concentrations of fumed silica AEROSIL® 200
NPs (3.0 and 6.0 μg/cm2). Seven relevant canonical pathways disturbed after 24 h and 72 h exposure with two doses of NPs (3.0 and 6.0 μg/cm2) were
revealed with the Ingenuity Pathway Analysis tool. Each canonical pathway is constituted of a finite number of genes. For each dose and time point,
we calculated a ratio indicating the percentage of altered genes in our dataset belonging to a given canonical pathway. These pathways are all
significant according to a Fisher statistical test (p-value < 0.05).
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naling pathway” and “actin cytoskeleton remodeling”; they
presented low ratios but were obtained with high signifi-
cance. This allowed specific cellular effects triggered as a
function of increasing NP concentrations to be distin-
guished and to be classified at three hierarchical levels of
toxicological response. The Additional file 3: Table S3 in-
dicates more precisely the genes characterizing each path-
way for the three levels at all NP concentrations (1.5, 3.0,
and 6.0 μg/cm2), with their fold changes and p-values.
Exoproteomic analysis
We used several tools such as SignalP, SecretomeP,
Exocarta, and Vesiclepedia to distinguish the proteins
secreted by classical (endoplasmic reticulum/golgi) and
non-classical (such as exosomes and microvesicles) export
mechanisms from those that were not secreted at 24 h ex-
posure. We then identified their implication in toxico-
logical functions using the IPA database.
Thus, at 3.0 μg/cm2, 10 proteins had a signal peptide
(score SignalP ≥ 0.9) and were likely secreted by classical
mechanisms. In addition, 61 proteins were found in the
Exocarta/Vesiclepedia databases and 22 proteins were
identified with SecretomeP (without signal peptide and a
score ≥ 0.5), representing 64 proteins potentially secreted
by non-classical mechanisms. Finally, by appending all
databases, it was found that 67/72 proteins were se-
creted. Remarkably, five proteins were not found with
these tools and were considered as possible cellular
waste with high half-lives in the extracellular compart-
ment: histone H4 (H4), T-complex protein 1e (TCPE),T-complex protein 1b (TCPB), tubulin b (TBB5) and
transitional endoplasmic reticulum ATPase (TERA).
At 6.0 μg/cm2, eight proteins had a signal peptide (score
SignalP ≥ 0.9) and were secreted by classical mechanisms.
At this dose, 71 proteins were found in the Exocarta/
Vesiclepedia databases and 26 proteins were identified with
SecretomeP (without signal peptide and a score ≥ 0.5),
representing a total of 73 proteins potentially secreted by
non-classical mechanisms. Finally, by merging all data-
bases, it was found that 74/79 proteins were actually se-
creted and five proteins would possibly be cellular waste:
heterogeneous nuclear ribonucleoproteins A2/B1 (ROA2),
transitional endoplasmic reticulum ATPase (TERA), his-
tone H4 (H4), kynureninase (KYNU), and tubulin beta
chain (TBB5).
Three predominant toxicological pathways were iden-
tified with IPA. The “NRF2-mediated oxidative stress re-
sponse” was triggered. Among the proteins involved in
the NRF2 response, six and seven proteins were identi-
fied at 3.0 and 6.0 μg/cm2, respectively. The “xenobiotic
metabolism signaling” was also involved, with five and
six proteins at 3.0 and 6.0 μg/cm2, respectively. These
proteins include heat-shock proteins (HSP70 and HSP90),
detoxification enzymes such as glutathione reductase
(GSR), glutathione S-transferase (GSTP1), lactate de-
hydrogenase (LDHA), peroxiredoxins (PRDX1, PRDX6),
thioredoxin reductase (TRXR1), protein disulfide isomerase
(PDIA6), and aldo-keto reductases (AKR1B1, AKR1B10,
AKR1C1/C2, and AKR1C3). All proteins were upregulated
and detected with high sequence coverage (Additional
file 2: Table S2).
Pisani et al. BMC Genomics  (2015) 16:315 Page 7 of 14Among the non-classically secreted proteins, some,
initially involved in glycolysis, were upregulated. The list
includes enolase 1 (ENO1), glyceraldehyde-3-phosphate
(GAPDH), aldolase A (ALDOA), glucose-6-phosphate
isomerase (GPI), phosphoglycerate mutase 1 (PGAM1),
phosphoglycerate kinase 1 (PGK1), triosephosphate isom-
erase 1 (TPI1), and pyruvate kinase (PKM). Interestingly,
only four proteins were downregulated compared to
controls: thrombospondin-1 (TSP-1; −4.5 and −9.0 at
3.0 and 6.0 μg/cm2, respectively), transforming growth
factor beta-induced (TGFbI; −4.375 at 6.0 μg/cm2),
agrin (AGRN; −21.0 at 6.0 μg/cm2), and nucleobindin 1
(NUCB1; −4.33 at 6.0 μg/cm2).
Discussion
This work evaluated the mode of action of AEROSIL®
200 fumed amorphous silica NPs in lung epithelial cells
using complementary omics. We chose this cellular
model because inhalation is the major route of exposure
for workers in the NP industry. Any toxicity study with
nanoparticles requires a thorough characterization of their
size. We showed by atomic force microscopy (Figure 1A)
that these NPs were disks with average diameter 10 ±
5 nm and thickness 2 nm± 0.3 nm. We also highlighted
the presence of heterogeneous agglomerates (Figure 1B)
of average size 160 ± 90 nm. Hydrodynamic diameters of
fumed silica NPs were measured by DLS in the presence
and absence of fetal bovine serum (FBS) in the culture
medium. In the presence of FBS, these NPs were dis-
persed, with a mean size of 10 ± 4 nm in agreement with
the data from the literature [19] and consistent with the
data provided by the manufacturer i.e. 12 nm. In the ab-
sence of FBS, the silica NPs formed agglomerates whose
hydrodynamic diameter reached 350 ± 8 nm. Interestingly,
AFM identifies the size and shape of objects whereas DLS
provides only their size. Cell exposure was carried out in
the absence of serum for two reasons: i) the exoproteome
can only be assessed if contaminants from the culture
medium and reagents are present in low quantities [16],
and ii) attempts to avoid agglomeration by artificial disper-
sion may lead to underestimation of possible adverse ef-
fects [20]. Indeed, interactions between serum proteins
and nanoparticles can attenuate or abrogate the poten-
tially harmful effects of NPs [21-23].
The concept of NOTEL
Previous studies have shown that the number of modu-
lated genes in human cells may be a good indicator of
the level of cellular disturbance induced by a xenobiotic
(drugs, chemicals, metals, NP) [11,24-27]. The concept
of the NOTEL (no observed transcriptional effect level,
the concentration at which no effect on the transcrip-
tome is observed) was described by Lobenhofer et al.
[13]. Incorporating a genomic endpoint such as theNOTEL, estimated from gene expression data, is of the
highest importance in risk assessment [14]. We used
conventional viability tests, ATP and XTT (Figure 2),
and cell impedance monitoring (xCELLigence) (Figure 3)
as preliminary tests to determine suitable NP concentra-
tions and time points for subsequent toxicogenomic stud-
ies. With these preliminary techniques, we were thus able
to frame the concentrations that were necessary and suffi-
cient to trigger early effects on cellular mechanisms [28]
while avoiding excessive cellular damage. Five concentra-
tions (0.1, 1.0, 1.5, 3.0, and 6.0 μg/cm2) inducing less than
10% cell death were chosen for transcriptomic experi-
ments. A 24 h exposure was set as the early effect test ac-
cording to impedance results. The 3.0 and 6.0 μg/cm2
doses were also analyzed in gene expression microar-
rays with an exposure of 72 h (late effects). The secre-
tomes corresponding to cultures exposed to these two
concentrations for 24 h were studied by tandem mass
spectrometry.
We noted that the NOTEL (1.0 μg/cm2) was lower
(i.e. more sensitive) than the NOAEL identified with
cytotoxicity assays (1.5 μg/cm2), as shown in Figure 4.
The LOTEL based on transcriptomics was also lower
(1.5 μg/cm2) than the LOAEL determined from cell
viability (3.0 μg/cm2). Thus, in our experiment, microarray
technology may be considered to be more sensitive
compared to viability tests. The NOTEL may be a rele-
vant indicator of biological exposure to quickly bench-
mark toxic doses of chemicals and mixtures, especially
within the framework of large toxicology programs such
as REACH [13,14].
Advantages and pitfalls of omics
The data obtained with our two complementary omics
approaches, transcriptomics and exoproteomics, were
analyzed using the same bioinformatics tool (IPA), and
the biological results were combined resulting in an il-
lustrative example of toxicological integrative analysis.
The Venn diagrams showed that more than 80% of
genes (Figure 5A) and proteins (Figure 5B) modulated at
3.0 μg/cm2 were also listed as modified at 6.0 μg/cm2.
The two approaches are thus consistent and the results
obtained at the two NP doses reinforce the main toxico-
logical findings extracted from the data. The canonical
cellular pathways help to understand, in a fast and over-
all manner, the interactions between the modulated
genes and the cellular mechanisms they belong to. The
main pathways disturbed by silica NPs are represented
in Figure 6. Regulation of gene expression is so finely
tuned that two distinct experimental conditions can acti-
vate different transcripts (subunits of the same enzym-
atic complex, early or late molecules and redundant
receptors), while belonging to the same pathway govern-
ing the same mode of action. Thus, looking at the overall
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derstanding of cellular mechanisms involved in the re-
sponse to a toxic substance. A fortiori, analyzing the
direction of regulation (induction or repression) of each
regulated molecule seems pointless in such large
eukaryotic systems, and in the state of our current know-
ledge. Moreover, the mRNAs are produced in an oscilla-
tory manner (in bursts) according to Raj et al. [29]. Their
production is likely to obey finely tuned processes that we
do not necessarily know. Nevertheless, analyzing a direc-
tion of regulation is certainly more significant with multi-
dose and multi-time analyses; potentially conserved regu-
lations could therefore be confirmed. This is why, here,
we operated microarrays at several times of exposure and
doses of fumed silica NPs.
Regarding the analysis of proteins in the culture super-
natants, comprehensive exoproteomics is tedious to per-
form because of the highly diluted nature of secreted
proteins present in biological fluids or culture media
[30]. Consequently, we had to concentrate the superna-
tants by precipitation prior to their analysis with a sensi-
tive tandem mass spectrometer. In addition, one cannot
exclude the possibility that some proteins may be re-
leased in the supernatant by cell death or lysis during
the cell culture. This pitfall was minimized by optimizing
experimental parameters (confluence maintained at 80%,
intensive washing steps prior to exposure and upstream
selection of appropriate NP doses) and using specific
bioinformatics tools (SignalP, SecretomeP, Exocarta,
Vesiclepedia) to distinguish the proteins that were genu-
inely excreted from those proteins arising from cell lysis.
These secreted proteins illustrate the surroundings of
the cells and how they interact with their environment.
Dose-dependent hierarchical response
The hierarchical oxidative stress paradigm, first de-
scribed by A. Nel and colleagues [28,31], posits that
ROS production leads to incremental cellular responses
that can be classified as antioxidant defense, proinflam-
matory effects, and cytotoxicity. According to these au-
thors, in Tier 1, the transcription factor Nrf2 is activated
to enhance the expression of phase II enzymes, which
attempt to restore redox equilibrium. If the level of oxi-
dant injury increases (Tier 2), cells express proinflamma-
tory cytokines by activating signaling pathways such as
the mitogen-activated protein kinase (MAPK) and nu-
clear factor-kappa B (NF-κB) cascades. At the highest
level of oxidative stress (Tier 3), interference in mito-
chondrial inner membrane electron transfer or changing
the open/closed status of the permeability transition
pore could lead to effects on ATP synthesis and the re-
lease of proapoptotic factors.
In this study, we illustrated this paradigm to demon-
strate that increasingly severe cellular dysfunctionswere triggered by silica NPs in a dose-dependent manner
(Figure 7). Moreover, our data show cellular mechanisms
that occur at lower doses than those that activate oxida-
tive stress.
No effect (Level 0)
As depicted in Figure 7, from 0.1 to 1.0 μg fumed silica
NPs per cm2 cell surface, no effect was detected by tran-
scriptomics. The NOTEL point, the highest concentra-
tion of NPs giving no transcriptional effect, was set to
1.0 μg/cm2, as two successive values gave no effect.
Internalization, externalization (Level 1)
At a very low dose of fumed silica NPs (1.5 μg/cm2), we
observed an intense signaling activity (Additional file 3:
Table S3). Here, we highlighted five induced transcripts
belonging to the pathway “clathrin-mediated endocyto-
sis” (ACTA1, EPS15, HIP1, ORM1 and VEGFA). This
pathway is the major pathway for the internalization of
exogenous molecules from the plasma membrane into
intracellular compartments. We also observed the in-
duction of downstream effectors of the “Rho signaling
pathway” (ROCK1, ARHGAP24, PPP1R12B and RAP-
GEF group). Rho signaling attests to a cytoskeleton
reorganization by stimulating actin dynamics. Rho
GTPases regulate membrane trafficking and are im-
portant regulators of exocytosis through a process not
yet elucidated [32,33].
We did not observe, among the 255 genes differen-
tially expressed at this concentration, any element of
antioxidant response. Typically, in our first level, we de-
scribe some events that are well below the events de-
scribed by Nel and colleagues in their Tier 1, i.e.
oxidative stress [28,31]. A possible reason may be that
antioxidant defense has been shown to be triggered by a
higher concentration (>5 μg/cm2) [34], and another ex-
planation is that our technology is extremely sensitive in
apprehending very subtle events. In our data, the first
level rather reflects the endocytosis and exocytosis of
NPs, as attested by the cytoskeleton remodeling and
membrane trafficking. This likely corresponds to a nor-
mal response of cellular defense.
Inflammation and nonspecific response (Level 2)
Starting from the 3.0 μg/cm2 dose, upregulation of in-
flammatory mediators (IL-6, IL-8 and TNF-α) and che-
mokines (CCL5 and CCL20) was observed in a dose-
dependent manner at 24 h exposure (Additional file 3:
Table S3). These results are consistent with those found
in the literature for silica and other NPs [4,35,36]. Perkins
et al. previously compared crystalline and amorphous sil-
ica NPs, but found that only cristobalite upregulated IL6
and IL8 in lung BEAS- 2B cells whereas amorphous silica
NPs only modulated CCL5 (RANTES) expression [4].
Figure 7 Hierarchical stress response following exposure to increasing concentration of AEROSIL® 200 fumed amorphous silica NPs. A549 cells
(n = 3) were exposed for 24 h to increasing concentrations of fumed silica AEROSIL® 200 NPs (0.1, 1.0, 1.5, 3.0 and 6.0 μg/cm2). Between 1.0 and
1.5 μg/cm2, the silica NPs activated Rho signaling pathways and clathrin-mediated endocytosis. From 3.0 μg/cm2, proinflammatory effectors were
activated and the “coagulation system pathway” was triggered. Beyond 6.0 μg/cm2, the pathways of “xenobiotic metabolism” and “acute phase
response” were activated. The vertical scale represents the percentage of dead cells, as determined by ATP assays, in relation to the tested doses
of silica NPs. These data exemplify the paradigm of dose dependent toxic events developed by Meng et al. [28]. This figure is freely adapted from
their scheme with permission from Meng et al. [28], American Chemical Society, although the quantitative data and pathways are those obtained
in experiments described in the current article.
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but also CCL5 and CCL20, were upregulated in the pres-
ence of AEROSIL® 200 fumed silica NPs, with a fold
change of 4.5 and 10.2 at 3.0 and 6.0 μg/cm2, respectively.
This discrepancy between our data and previously pub-
lished data illustrates the possible heterogeneity of the re-
sults in the NP literature, probably directly linked to the
different nature of the NPs. In particular, fumed AERO-
SIL® 200 NPs differ from the amorphous silica NPs of the
previous study [4], with a surface area 100 times greater.
The “TREM1 signaling pathway” was triggered, leading to
proinflammatory immune responses. The TREM1 tran-
script, which belongs to the immunoglobulin family of cell
surface receptors, was upregulated at 6.0 μg/cm2.
Coagulation system perturbation as a specific response
(Level 2)
At higher concentrations (3.0 and 6.0 μg/cm2), and for
two exposure durations (24 and 72 h), the canonical
“coagulation pathway” was altered by fumed silica NPs
(Figure 6). This pathway, and more specifically the “in-
trinsic and extrinsic prothrombin activation” subgroups,
is the most significant altered pathway. Besides the
known functions of the alveolar epithelium, such as sur-
factant secretion (to maintain alveolar stability), gas ex-
change, and ion transport, these cells also have barrierproperties that protect against the passage of air pollut-
ants into the circulation [37]. These authors also demon-
strated that in A549 cells, the coagulation process
responds to injury by the rapid formation of a clot and
fibrin deposition [38].
Our data thus suggest that this pathway is a direct
consequence of the alteration of the A549 cell mono-
layer by fumed silica nanoparticles, probably due to cell
membrane alteration. Indeed, as demonstrated by Zhang
and colleagues, fumed silica NPs (AEROSIL, diameter
16 nm) induce a dramatically higher cytotoxicity than
colloidal silica in lung cells BEAS-2B [27]. The authors
explained the increased toxicity of fumed silica by its
thermally promoted surface properties, i.e. the formation
of strained, three-membered siloxane rings on the silica
surface via dehydroxylation. These rings are rapidly hy-
drolyzed upon rehydration in culture medium, exposing
hydroxyl groups responsible for cell toxicity by inter-
action with cell membranes. In our proteomic data, the
cell membrane alteration is confirmed by the release of
the LDH protein, which is an indicator of cell membrane
integrity.
Coagulation is a complex process that can be initiated
via the extrinsic or intrinsic pathways. In the extrinsic
pathway, a cascade of activation including factor VIIa
(F7) and tissue factor (TF) leads to the generation of
Figure 8 Changes in the mRNA expression measured by transcriptome
and by real-time PCR. The fold changes of FGA, F2, PLAU, FGG, F7, and
PROC in cells treated with fumed silica AEROSIL® 200 NPs (6.0 μg/cm2
at 72 h) are expressed versus untreated cells. For qRT-PCR (n = 6)
normalization was based on the total RNA mass quantified on the
Nanodrop. All expressions in treated cells were significantly
different from controls at p < 0.05. These genes are all connected to
the “coagulation pathway” and the qRT-PCR findings confirm
transcriptomic data.
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creates a clot. In the intrinsic pathway, a cascade of acti-
vations leads to the production of coagulation factors
such as FXa (F10). The coagulation system includes a
number of control proteins to maintain a fine balance
between formation and dissolution of the clot. Plasmin
is one of these proteins that are required for dissolution
of the fibrin clot. Plasmin is activated by tissue plas-
minogen activator (PLAT) and urokinase (PLAU). Pro-
tein C, protein S, and thrombomodulin together degrade
FVa and FVIIIa.
The modifications of expression of the key actors in
the coagulation process are given in Additional file 3:
Table S3. F2 (thrombin), F7, F10 and F13b are downreg-
ulated, as are FGA, FGB and FGG (fibrinogen chains),
and KLK1 (kallikrein 1). THBD (thrombomodulin) is
upregulated, likely reducing coagulation and activating
the anticoagulant pathway. PROC, PROS1, and TFP1
(lipoprotein-associated coagulation inhibitor) are also dif-
ferentially expressed in our datasets. In addition, PLAT
(tissue plasminogen activator), PLAU (urokinase), and
PLAUR are upregulated. These participate in the conver-
sion of plasminogen to plasmin, thus activating fibrinolysis
to dissolve fibrin clots.
Although the interpretation of the direction of the
regulation (up or down) of each individual molecular
component of a pathway is far from being straightfor-
ward in such a complex system, it is interesting to note
that key molecules of the coagulation system have a con-
served modulation with both dose and time of exposure.
The modifications in expression of the main transcripts
of the coagulation system were confirmed by qRT-PCR
(Figure 8).
Hence it is difficult to determine if these genes activate
wound healing by fibrinogenesis or if, on the contrary,
they destroy fibrin clots by fibrinolysis. It is likely that
both mechanisms are at work, as the coagulation system
responds to injury through a cascade of events leading
to the formation of a clot that is eventually degraded and
resorbed through the process of fibrinolysis. It is possible
that, at 24 h and 72 h after exposure, only the final stage
of the process is detectable. Proteomics revealed the inhib-
ition of thrombospondin (TSP-1) which participates in the
plasminogen activation and fibrinolysis [39].
According to Napierska et al., inhaled particles are in-
volved in a procoagulant response in lung models [40].
Available data from experimental instillation/inhalation
of engineered nanoparticles are supportive of the hy-
pothesis that a pulmonary and/or systemic inflammatory
response induces a procoagulatory state [41,42]. There-
fore, in coherence with the literature, our data support
an effect of these silica nanoparticles on the coagulation
system, and argue for the involvement of this specific
mechanism starting at level 2.Toxic oxidative stress (Level 3)
At the 6.0 μg/cm2 dose, we observed by transcriptomics
the first signs of oxidative stress (Additional file 3: Table
S3), caused by an imbalance between the production of
reactive oxygen and the detoxification of reactive inter-
mediates, especially the NRF2 signaling cascade, antioxi-
dant molecules (SOD, GPX2), and phase I and phase II
enzymes (GST, EPHX1,GCLC and AOX1). Proteomics
clearly indicated the presence of the “NRF2-mediated
oxidative stress response”, with the induction of the en-
zymes, PRDX1(R = 6.4) and TXNRD1(R = 13).
Our transcriptomics results highlighted the “acute phase
response signaling” pathway, a nonspecific defense mechan-
ism. This pathway is triggered by tissue injury and charac-
terized by the upregulation of proinflammatory cytokines
and acute phase proteins such as NFKB2, IL6, and SOD2
at 3.0 and 6.0 μg/cm2. “Xenobiotic metabolism signaling”
is also activated, with several transcripts encoding en-
zymes such as ALDHA, MAP2K3, and TNF at 6.0 μg/cm2.
Proteomics confirmed this trend with the overexpression
of aldehyde dehydrogenase ALDHA (FC =20.4 and 21.5),
glutathione transferase GSTP1 (FC = 11.0 and 11.3), and
heat-shock protein HSP90A (FC = 14.2 and 19.4), at 3.0
and 6.0 μg/cm2, respectively.
Toxicogenomics and risk assessment
The hierarchical response of alveolar epithelial lung cells
(Figure 7) illustrates quantitatively the perspectives
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ing the safety assessment of nanomaterials.
The genome-wide response to nanomaterial exposure
remains largely unexplored and the use of omics tech-
nologies in the safety assessment of nanomaterials would
be interesting for predictive toxicology [25]. We have
demonstrated that toxicogenomics can provide a quanti-
tative assessment of toxicity and, at the same time, gives
information about the mode of action of toxicants, pos-
sibly revealing adverse outcome pathways (AOPs). In
their vision and strategy for toxicity testing in the 21st
century, the National Research Council cited the linkage
of adverse effects to specific toxicity pathways and “Ap-
plications of Toxicogenomic Technologies to Predictive
Toxicology and Risk Assessment”. Recently, EFSA deliv-
ered a scientific report recommending for future work
and research the use of omics technologies and AOPs in
the context of the prioritization of chemicals for risk as-
sessment [44].
In our study, the use of these two techniques allowed
us to establish a precise dose–response curve of fumed
silica NPs, with a NOTEL, and to link these doses to
specific pathways, allowing insights into mechanistic in-
formation for both intracellular and extracellular
compartments.
Conclusions
Transcriptomic and proteomic approaches were com-
bined in the current study to investigate quantitatively
the effects of AEROSIL® 200 fumed silica NPs in A549
epithelial lung cells, and within their close environment
to decipher their mode of action. Such an alliance of
omics has rarely been reported regarding the toxico-
logical effects of NPs. Our main findings allowed the set-
ting of a NOTEL (no observed transcriptional effect
level) for fumed silica NPs at 1.0 μg/cm2, a threshold
lower than values previously obtained with conventional
viability tests. Moreover, the NOTEL may be a relevant in-
dicator of biological exposure for use in quickly bench-
marking doses of chemicals and mixtures in toxicology.
These techniques allowed us to establish a hierarchical
dose–response curve of fumed silica NPs, linking doses
to adverse outcome pathways, and delivering not only
quantified cytotoxic values but also mechanistic infor-
mation for both the intracellular and extracellular com-
partments. Monitoring the overall effects rather than
those of isolated genes/proteins thus allows for a better
understanding of the cellular mechanisms involved in
the response to a toxic substance, without losing the
possibility to analyze very specific molecular effects. As
in photography, toxicogenomics allows, at the same
time, the acquisition of a wide vision of biological re-
sponses and a “zoom” into the details with a great depth
of field. Indeed the hypotheses generated by these resultsregarding a specific adverse effect can be studied further
with more focused techniques. This approach might be
adapted to any type of potentially toxic substance, alone
or in a mixture, in cellular models as a predictive tool for
toxicity assessment in a future regulatory perspective.
Methods
Nanoparticle characterization
AEROSIL® 200 particles (hydrophilic fumed silica, from
Evonik, Germany) are extrapure (SiO2 > 99.8%), nano-
sized (12 nm diameter), and have a high specific surface
area of 200 m2/g, according to the supplier. These nano-
particles were used “as received”. The aggregation states
of the nanoparticles were analyzed by dynamic light
scattering (n = 3) in the culture medium, with/without
serum, using the Zetasizer Nano ZS (Malvern Instru-
ments Ltd, UK). Atomic force microscopy imaging was
performed with a Multimode and Nanoscope V instru-
ment (Veeco, Santa Barbara, CA, USA) mounted with
an EV Scanner and silicium tips (K = 0.58 N/nm, Bru-
ker). Sample preparation consisted of the deposition of
5 μl SiO2 NP suspension (at 10 μg/ml in pure water) on
freshly cleaved Mica (Muscovite from SPI, France). After
1 min., the sample was dried under vacuum. Amplitude
and height images were recorded in peak force mode. The
resulting pictures were plane-fitted and flattened with the
supplied Nanoscope Analysis software (Brucker) V 1.40.
Cell culture
The A549 human alveolar epithelial cell line (CCL −185™)
was obtained from the American Type Culture Collection
(ATCC, Manassas, VA, USA). Cells were cultured in
DMEM/F12 medium (Invitrogen) supplemented with 10%
fetal bovine serum (FBS) and 1% penicillin/streptomycin
(100 U/mL, 100 μg/mL) and incubated in a humidified in-
cubator at 37°C and 5% CO2. Cells were used between
passages 20 to 40. Cells were passed twice a week and
the medium was changed three times per week, keeping
confluence below 80%.
Cell viability tests
ATP tests. A549 cells were grown in 96-well plates. The
cells were exposed for 24 h at serial dilutions of SiO2
NPs in serum-free medium (from 0.3 μg/cm2 to 30.3 μg/
cm2 of cell surface). Cells were washed with PBS and cell
viability was determined by the ATP test (Cell Titer-Glo
luminescent cell viability Assay), as specified by the sup-
plier (Promega). Briefly, 100 μl kit reagent were added
per well and the plate was shaken for 10 min. at RT be-
fore measuring bioluminescence with a LUMIstar Galaxy
instrument (BMG).
XTT tests. A549 cells were grown in 96-well plates.
The cells were exposed for 24 h at serial dilutions of
SiO2 NPs in serum-free medium. Cells were washed with
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(Sigma-TOX2, In Vitro Toxicology Assay Kit, XTT based),
as recommended by the supplier (Sigma-Aldrich). Briefly,
20 μl kit reagent were added per well and the plate was in-
cubated for 2 h at 37°C before reading the absorbance at
450 nm and 690 nm with a Multiscan Spectrum spectro-
photometer (Thermo Electron Corporation).
Real-time impedance measurement (Xcelligence)
A background resistance of the E-plates (ACEA) was de-
termined with 100 μl culture medium. A549 cells were
seeded in E-plates at 10,000 cells in 100 μL. E-plates
were placed into the Real-Time Cell Analyzer (RTCA)
station (ACEA) and incubated at 37°C. Cells were grown
for 24 h, with impedance measured every minute during
14 h (adhesion phase), then every 15 min. (growth
phase) for 14 h. After 28 h, cells were exposed (n = 3) to
SiO2 NPs at 1.5, 3.0, 6.0, 25, and 50 μg/cm
2, and were
monitored every minute during 12 h (early effects) then
every 15 min. for 100 h (late effects). The impedance of
control cells without SiO2 NPs was also recorded. Cell
index (CI) raw data values were calculated by the appar-
atus software (RTCA software 2.0). Normalized cell in-
dexes were also calculated by the software at a selected
normalization time point, which was chosen as the time
just before the addition of nanoparticles.
Microarrays (Agilent Human V2 4x44K)
A549 cultures (biological triplicate) were exposed to five
concentrations of SiO2 NPs (0.1, 1.0, 1.5, 3.0, and 6.0 μg/
cm2) and serum-free medium (control cells) for 24 h,
and exposed to two concentrations of SiO2 NPs (3.0 and
6.0 μg/cm2) for 72 h. Total RNAs were extracted using
the RNeasy Mini Kit (Qiagen). RNAs were quantified
with the NanoDrop 1000 spectrophotometer and their
qualities were assessed with the Agilent 2100 Bioanaly-
zer (Agilent). RNA samples were amplified and labeled
with cyanine-3 fluorophore using a Low Input Quick
Amp Labeling Kit (Agilent). Hybridization (n = 3) was
performed with Human V2 4x44K oligo microarrays
(Agilent). Fluorescence was scanned (Agilent Scanner)
and signal data were extracted with Feature Extraction
software (Agilent).
Statistical analysis for transcriptomics
Five independent analyses were conducted, namely SiO2
NP-exposed cells versus control cells at five different
concentrations: 0.1, 1.0, 1.5, 3.0, and 6.0 μg/cm2. For
each analysis, six fluorescence data files (three for ex-
posed cells and three for control cells) were submitted
to GeneSpring GX 11 software (Agilent Technologies)
using a widespread method for determining the signifi-
cance change of gene expression [45,46]. The fold
change cutoff between control and exposed samples wasset to 1.5. Genes significantly up- or downregulated were
determined by an unpaired t-test with a p-value below
0.05 and a Benjamini-Hochberg false discovery rate cor-
rection. We thus obtained lists of genes that were signifi-
cantly induced or repressed after exposure to NPs.
qRT-PCR validation of microarray data focused on
coagulation
Validation of whole-genome expression microarray was
performed by qRT-PCR on a representative list of signifi-
cant genes. Total RNA was isolated according to the man-
ufacturer's instructions using the RNeasy kit (Qiagen) and
treated with DNase. RNA purity and concentration were
determined by UV on a Nanodrop® Spectrophotometer
and integrity was assessed on an Agilent 2100 Bioanalyzer
(Agilent Technologies). Differential analysis of transcripts
from cells exposed to 6.0 μg/cm2 SiO2 NPs for 72 h versus
unexposed cells was performed by qRT-PCR on Opticon
II (Biorad) with the Sybr Green PCR Master Mix
(Finzyme) kit according to the manufacturer's instruc-
tions. Measurements were means of sextuplets (duplicates
of three independent experiments). Primer sequences are
listed in the Additional file 4: Table S4.
Sample preparation for shotgun proteomics and tandem
mass spectrometry
Culture supernatants of control cells and those exposed
to fumed silica NPs during 24 h were collected and
pooled (v = 2.5 mL per condition, biological triplicates).
Proteins from each sample were precipitated with 10%
trichloroacetic acid after the addition of a one-quarter
volume of trichloroacetic acid at 50% (w/vol). The solu-
tions were vortexed and then incubated on ice for
10 min. The samples were centrifuged at 16,000 g for
10 min. at 4°C. The resulting pellet was dissolved in
45 μl 1X LDS (Invitrogen). These samples were heated
at 99°C for 5 min. and then loaded onto a 10% NuPAGE
gel (Invitrogen) for a short electrophoresis in MOPS
buffer. The polyacrylamide bands containing the whole
exoproteomes were processed as previously described
[47]. The resulting peptides (10 μl of the 40 μl generated
with the procedure) were analyzed with an LTQ-
Orbitrap XL hybrid mass spectrometer (ThermoFisher)
coupled to an UltiMate 3000 Nano LC System (Dionex-LC
Packings), as described previously [48].
Protein identification and quantification by shotgun
proteomics
The MS/MS spectra were searched against the SwissProt
database (release SwissProt_2013_01.fasta) totaling 65,754
protein sequences from mammals. Searches for trypsic
peptides were performed with the following parameters:
full-trypsin specificity, a mass tolerance of 5 ppm on the
parent ion and 0.5 Da on the MS/MS, carbamidomethyl
Pisani et al. BMC Genomics  (2015) 16:315 Page 13 of 14Cys as static modification and oxidized Met as dynamic
modification, and maximum number of missed cleavages
set at 2. All peptide matches with a peptide score below a
p-value of 0.05 were filtered. A protein was considered to
be validated when at least two different peptides were de-
tected in the same experiment. The false-positive rate for
protein identification was estimated using the appropriate
decoy database as below 1%. The number of MS/MS spec-
tra per protein (spectral counts) was determined for each
sample. Spectral counts were then compared using the
TFold method of the PatternLab software [49]. Fold
change and p-value cutoffs were set at 2.0 and 0.05,
respectively.
Integrative biological analysis
Cellular function and localization of identified genes and
proteins were obtained with the Ingenuity Pathway Ana-
lysis software (Ingenuity Systems, US).
Lists of genes or proteins significantly induced or re-
pressed after exposure to NPs were uploaded into In-
genuity Pathway Analysis software for biological analysis
by comparison with the Ingenuity Knowledge Database.
These lists of altered genes or proteins were then proc-
essed to investigate their functional distribution, as de-
fined by Gene Ontology. Datasets were analyzed with
several tools such as SecretomeP, SignalP, Exocarta and
Vesiclepedia. Known canonical pathway associations
were measured by IPA by using a ratio of the number of
genes or proteins from datasets that map to the pathway
divided by the total number of constitutive genes or pro-
teins that map to the canonical pathway. A Fisher’s exact
test was used to determine a p-value representing the
significance of these associations.
Availability of supporting data section
The data sets supporting the results of this article are
available as Additional files. The raw data discussed in
this publication have been deposited in the NCBI Gene
Expression Omnibus (GEO) repository and are access-
ible through GEO Series accession number (http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE63806).
Additional files
Additional file 1: Table S1. List of genes significantly differentially
expressed upon exposure to AEROSIL® 200 fumed amorphous silica NPs
versus control cells. Three different A549 cultures were exposed to five
concentrations of SiO2 NPs (0.1, 1.0, 1.5, 3.0, and 6.0 μg/cm2) and serum-free
medium (control cells) for 24 h, and to two concentrations (3.0 and
6.0 μg/cm2) for 72 h. Hybridization (n = 3) was performed with Human
V2 4x44K oligo microarrays (Agilent). The fold change cutoff between
control and exposed samples was set to 1.5. Genes significantly up- or
downregulated were determined by an unpaired t-test with a p-value
below 0.05 and a Benjamini-Hochberg false discovery rate (n = 3).
Additional file 2: Table S2. List of proteins identified in the
exoproteome by nanoLC-MS/MS. Spectral counts per protein measuredfor each of the nine samples; control (Ctrl), first concentration (C1), and
second concentration (C2), with three replicates, are indicated, as well as
the PatternLab statistical results (fold change, p-value, signal +, signal -,
class) for the three possible comparisons (C1 versus Crtl; C2 versus Crtl;
C2 versus C1). The patternLab classes are: blue (identifications that
satisfied both the fold and statistical criteria), orange (identifications that
did not meet the fold criterion but have low p-values), green (identifications
that satisfied the fold criteria but this was most likely to have happened by
chance), and red (identifications that did not meet the fold and p-value
criteria).
Additional file 3: Table S3. List of genes and proteins supporting the
hierarchical stress response. A549 cells were exposed to 1.5, 3.0, and
6.0 μg/cm2 silica NPs for 24 h. Fold changes of genes and proteins
significantly up- or downregulated were determined by an unpaired
t-test (p < 0.05) and a false discovery rate correction. Gene symbols are
indicated in italics, protein symbols are not italicized. * Transcripts whose
expression is identical in control cells and in NPs-exposed cells.
Additional file 4: Table S4. List of primers used in qRT-PCR. Differential
analysis of transcripts from cells exposed to 6.0 μg/cm2 SiO2 NPs for 72 h
versus unexposed cells was performed by qRT-PCR with the Sybr Green
PCR Master Mix (Finzyme) kit according to the manufacturer's instructions
on Opticon II (Biorad). This pool of genes represents the “coagulation
system” pathway.
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